首页> 美国卫生研究院文献>other >Usage of Adenovirus Expressing Thymidine Kinase Mediated Hepatocellular Damage for Enabling Mouse Liver Repopulation with Allogenic or Xenogenic Hepatocytes
【2h】

Usage of Adenovirus Expressing Thymidine Kinase Mediated Hepatocellular Damage for Enabling Mouse Liver Repopulation with Allogenic or Xenogenic Hepatocytes

机译:表达胸苷激酶介导的肝细胞损伤的腺病毒用于使小鼠肝重新繁殖同种或异种肝细胞的用途。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

It has been shown that the liver of immunodeficient mice can be efficiently repopulated with human hepatocytes when subjected to chronic hepatocellular damage. Mice with such chimeric livers represent useful reagents for medical and clinical studies. However all previously reported models of humanized livers are difficult to implement as they involve cross-breeding of immunodeficient mice with mice exhibiting genetic alterations causing sustained hepatic injury. In this paper we attempted to create chimeric livers by inducing persistent hepatocellular damage in immunodeficient Rag2-/- γc-/- mice using an adenovirus encoding herpes virus thymidine kinase (AdTk) and two consecutive doses of ganciclovir (GCV). We found that this treatment resulted in hepatocellular damage persisting for at least 10 weeks and enabled efficient engraftment and proliferation within the liver of either human or allogenic hepatocytes. Interestingly, while the nodules generated from the transplanted mouse hepatocytes were well vascularized, the human hepatocytes experienced progressive depolarization and exhibited reduced numbers of murine endothelial cells inside the nodules. In conclusion, AdTk/GCV-induced liver damage licenses the liver of immunodeficient mice for allogenic and xenogenic hepatocyte repopulation. This approach represents a simple alternative strategy for chimeric liver generation using immunodeficient mice without additional genetic manipulation of the germ line.
机译:已经显示,当遭受慢性肝细胞损伤时,免疫缺陷小鼠的肝脏可以有效地用人肝细胞再填充。具有这种嵌合肝脏的小鼠代表了用于医学和临床研究的有用试剂。但是,以前报道的所有人源化肝脏模型都难以实施,因为它们涉及免疫缺陷小鼠与表现出引起持续性肝损伤的基因改变的小鼠的杂交。在本文中,我们试图通过使用编码疱疹病毒胸苷激酶(AdTk)的腺病毒在免疫缺陷的Rag2 -/-γc-/-小鼠中诱导持续的肝细胞损伤来创建嵌合肝。和连续两次服用更昔洛韦(GCV)。我们发现这种治疗方法导致肝细胞损伤持续至少10周,并使人或同种异体肝细胞在肝脏内有效植入和增殖。有趣的是,虽然从移植的小鼠肝细胞中产生的结节具有良好的血管形成,但是人肝细胞经历了渐进的去极化作用,并且结节内的鼠内皮细胞数量减少了。总之,AdTk / GCV诱导的肝损伤允许免疫缺陷小鼠的肝脏进行异源和异源肝细胞的再繁殖。该方法代表使用免疫缺陷小鼠进行嵌合肝生成的简单替代策略,而无需对种系进行额外的遗传操作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号